Healthcare provider profile · identity verified

Loretta Jane Scism, M.D.

Family Practice · LANCASTER, OH · NPI 1336346865

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	424	118
Levothyroxine Sodium	Levothyroxine Sodium	293	75
Lisinopril	Lisinopril	285	82
Amlodipine Besylate	Amlodipine Besylate	242	73
Omeprazole	Omeprazole	230	61
Metoprolol Succinate	Metoprolol Succinate	193	51
Losartan Potassium	Losartan Potassium	173	47
Pantoprazole Sodium	Pantoprazole Sodium	146	44
Albuterol Sulfate Hfa	Albuterol Sulfate	138	63
Metformin Hcl Er	Metformin Hcl	132	37
Montelukast Sodium	Montelukast Sodium	124	31
Fluoxetine Hcl	Fluoxetine Hcl	121	42
Rosuvastatin Calcium	Rosuvastatin Calcium	112	40
Gabapentin	Gabapentin	111	34
Fluticasone Propionate	Fluticasone Propionate	107	48
Sertraline Hcl	Sertraline Hcl	107	29
Duloxetine Hcl	Duloxetine Hcl	102	27
Carvedilol	Carvedilol	101	28
Potassium Chloride	Potassium Chloride	101	33
Simvastatin	Simvastatin	100	33
Buspirone Hcl	Buspirone Hcl	99	34
Hydrochlorothiazide	Hydrochlorothiazide	97	29
Metformin Hcl	Metformin Hcl	96	31
Trazodone Hcl	Trazodone Hcl	94	31
Pravastatin Sodium	Pravastatin Sodium	89	24
Clopidogrel	Clopidogrel Bisulfate	80	24
Meloxicam	Meloxicam	79	20
Tamsulosin Hcl	Tamsulosin Hcl	74	21
Venlafaxine Hcl Er	Venlafaxine Hcl	74	16
Bupropion Xl	Bupropion Hcl	73	21
Famotidine	Famotidine	72	15
Mounjaro	Tirzepatide	69	12
Glimepiride	Glimepiride	67	20
Furosemide	Furosemide	66	25
Dicyclomine Hcl	Dicyclomine Hcl	64	13
Escitalopram Oxalate	Escitalopram Oxalate	60	18
Amitriptyline Hcl	Amitriptyline Hcl	57	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	19
Allopurinol	Allopurinol	53	suppressed
Ibuprofen	Ibuprofen	52	12
Jardiance	Empagliflozin	51	15
Tizanidine Hcl	Tizanidine Hcl	51	19
Alendronate Sodium	Alendronate Sodium	50	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	16
Ventolin Hfa	Albuterol Sulfate	48	13
Metoprolol Tartrate	Metoprolol Tartrate	46	15
Atenolol	Atenolol	45	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	13
Trulicity	Dulaglutide	45	13
Ketoconazole	Ketoconazole	44	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	43	14
Spironolactone	Spironolactone	43	15
Azithromycin	Azithromycin	40	34
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	40	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	16
Mupirocin	Mupirocin	38	24
Ropinirole Hcl	Ropinirole Hcl	38	12
Bupropion Hcl Sr	Bupropion Hcl	37	13
Chlorthalidone	Chlorthalidone	37	12
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Topiramate	Topiramate	35	suppressed
Baclofen	Baclofen	33	suppressed
Symbicort	Budesonide/Formoterol Fumarate	33	13
Spiriva Respimat	Tiotropium Bromide	32	suppressed
Sucralfate	Sucralfate	32	suppressed
Eliquis	Apixaban	30	11
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	30	13
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Hydroxyzine Hcl	Hydroxyzine Hcl	29	13
Cephalexin	Cephalexin	28	26
Triamcinolone Acetonide	Triamcinolone Acetonide	28	17
Warfarin Sodium	Warfarin Sodium	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Clonidine Hcl	Clonidine Hcl	26	suppressed
Fluconazole	Fluconazole	26	14
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Naproxen	Naproxen	21	suppressed
Torsemide	Torsemide	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Finasteride	Finasteride	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	15
Linzess	Linaclotide	18	suppressed
Nystatin	Nystatin	18	suppressed
Ozempic	Semaglutide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Valsartan	Valsartan	18	suppressed
Lovastatin	Lovastatin	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	13
Fenofibrate	Fenofibrate	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Erythromycin	Erythromycin Base	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Prednisone	Prednisone	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Estradiol	Estradiol	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Trospium Chloride	Trospium Chloride	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error